Skip to main content Skip to main navigation menu Skip to site footer

The role of various laboratory parameters associated with obstructive cholestatic jaundice in pancreatic tumor: A case report and literature review

Abstract

Introduction: Obstructive jaundice can be caused by pancreatic cancer, where most tumors block bilirubin excretion, and excess bilirubin accumulation causes jaundice. Jaundice occurs in more than 65% of pancreatic cancer patients. Jaundice is caused by the location of the tumor, usually located in the head of the pancreas, suppressing the bile ducts and creating a blockage characterized by an increase in bilirubin, especially direct bilirubin. Aspartate transaminase (AST) and alanine transaminase (ALT) may also be elevated in pancreatic cancer patients but to a lesser extent.

Case Presentation: A 63-year-old male patient presented with ocular symptoms and generalized jaundice that had lasted for 2 months. Patients also complain of a bloated stomach and feel thin due to continued weight loss. The patient's stool was the color of putty and brown, like viscous urine. A physical examination revealed conjunctival jaundice in both eyes and hepatomegaly. Abdominal ultrasonography (USG) results suggest a pancreatic head mass with a dilated pancreatic duct and edema of the gallbladder with dilated extrahepatic bile duct (EHBD). Laboratory tests showed that the patient had elevated liver function, total bilirubin 11.90 mg/dl, direct bilirubin 8.29 mg/dl, SGOT 33 U/l, SGPT 54 U/l, and three positive urinary bilirubin values. It became clear that. The patient was diagnosed by observing cholestatic jaundice and the differential diagnosis of suspected pancreatic cancer of the head and cholangiocarcinoma.

Conclusion: Examining laboratory parameters such as total bilirubin, especially direct bilirubin, liver enzymes SGOT, and SGPT may help localize obstructions, such as those caused by pancreatic tumors causing post hepatic obstructive jaundice. 

Section

References

  1. Fekaj E, Jankulovski N, Matveeva N. Obstructive jaundice. Austin Dig Syst. 2017;2(1):1–5.
  2. Joseph A, Samant H. Jaundice - StatPearls - NCBI Bookshelf [Internet]. StatPearls - NCBI Bookshelf. 2023 [cited 2023 May 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544252/
  3. Hoesin M, Bella Oktarina A, Bardiman Rasyad S. Karakteristik Penderita Kanker Pankreas di Instalasi Rawat Inap RSUP Dr. J Kesehat Makassar. 2015;47(1):22–30.
  4. Kadek N, Mahayanti S, Putu I, Sudarsana A. Laporan kasus: Kanker caput pankreas pada pasien dengan infeksi hepatitis B kronis. Intisari Sains Medis [Internet]. 2023;14(1):159–63. Available from: http://isainsmedis.id/
  5. Sánchez Márquez P, Rey Tovar MH, Garzón MA, Echeverry T. Recurrent benign intrahepatic cholestasis is a diagnostic challenge. Rev Colomb Gastroenterol. 2016;31(1):48–51.
  6. Shah R, John S. Cholestatic Jaundice - StatPearls - NCBI Bookshelf [Internet]. StatPearls - NCBI Bookshelf. 2023 [cited 2023 May 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482279/
  7. Mardi T, Arnelis. Intrahepatic and Extrahepatic Cholestatic Jaundice Caused by Adenocarcinoma Pancreas with Hepatitis B Infection: A Case Report. Biosci Med J Biomed Transl Res. 2022;6(9):2208–13.
  8. Shen Z, Tian L, Wang X. Treatment of pancreatic head cancer with obstructive jaundice by endoscopy ultrasonography-guided gastrojejunostomy: A case report and literature review. Med (United States). 2018;97(28):1–5.
  9. Niken P, Amrita A, Bintoro SUY. CASE REPORT Management strategy for an advanced head of pancreas carcinoma patient with obstructive jaundice. Drug Interv Today. 2020;13(6):1–2.
  10. Rikarni R. Pancreatic Cancer: Pathogenesis, Diagnosis, and Laboratory Tests. Indones J Clin Pathol Med Lab. 2021;27(3):333–40.
  11. Vogel A, Kullmann F, Kunzmann V, Al-Batran SE, Oettle H, Plentz R, et al. Patients with advanced pancreatic cancer and hyperbilirubinemia: Review and German expert opinion on treatment with nab-paclitaxel plus gemcitabine. Oncol Res Treat. 2015;38(11):596–603.
  12. Markovic AP, Stojkovic Lalosevic M, Mijac DD, Milovanovic T, Dragasevic S, Sokic Milutinovic A, et al. Jaundice as a Diagnostic and Therapeutic Problem: A General Practitioner’s Approach. Dig Dis. 2022;40(3):362–9.
  13. Nakata B, Amano R, Kimura K, Hirakawa K. Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis. Int J Surg [Internet]. 2013;11(4):344–9. Available from: http://dx.doi.org/10.1016/j.ijsu.2013.02.023
  14. Vroon DH, Israili Z. Alkaline Phosphatase and Gamma Glutamyltransferase. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 100. Available from: https://www.ncbi.nlm.nih.gov/books/NBK203/
  15. Jin X, Wu Y. Diagnostic utility of clinical and biochemical parameters in pancreatic head malignancy patients with normal carbohydrate antigen 19-9 levels. Afr Health Sci. 2015;15(1):123–30.

How to Cite

Dewi, N. M. R. P., I Nyoman Gde Sumardika, I Putu Sista Widya Utama, & Dwijo Anargha Sindhughosa. (2023). The role of various laboratory parameters associated with obstructive cholestatic jaundice in pancreatic tumor: A case report and literature review. Indonesia Journal of Biomedical Science, 17(2), 253–256. https://doi.org/10.15562/ijbs.v17i2.491

HTML
50

Total
67

Share

Search Panel

Ni Made Ratih Purnama Dewi
Google Scholar
Pubmed
IJBS Journal


I Nyoman Gde Sumardika
Google Scholar
Pubmed
IJBS Journal


I Putu Sista Widya Utama
Google Scholar
Pubmed
IJBS Journal


Dwijo Anargha Sindhughosa
Google Scholar
Pubmed
IJBS Journal